Miravo Healthcare™ Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of Shareholders
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare announces it will release its first quarter 2022 financial results on May 16, 2022, before market opening. This will coincide with the Company’s virtual Annual Meeting of Shareholders, starting at 9:00 a.m. ET. Registered shareholders can vote and submit questions during the meeting. Participants can join online, with access beginning at 8:45 a.m. ET. The Meeting Materials were mailed around April 22, 2022 and details for attendance can be found on the Company's website.
- None.
- None.
Details of the Meeting
The Meeting will take place online via live audio webcast on
Miravo’s Notice of Meeting, Management Information Circular (Circular) and the accompanying form of proxy (collectively the Meeting Materials) were mailed on or about
Registered Shareholders
A registered shareholder is a shareholder who holds common shares of the Company (Common Shares) in their own name (that is, not in the name of, or through an Intermediary). A registered shareholder who owns Common Shares on the Record Date (
Voting by Proxy
A registered shareholder who is unable to attend the virtual Meeting, or does not wish to personally cast their vote(s), may authorize another person at the Meeting to vote on their behalf. This is known as voting by proxy. Registered shareholders should follow the instructions on the form of proxy enclosed with the Circular to authorize another person (Appointee) to vote on their behalf at the Meeting. You must provide your Appointee the exact name and eight character appointee identification number to access the Meeting. Valid Appointees may attend the Meeting online, vote shares electronically and submit questions during the Meeting by visiting www.virtualshareholdermeeting.com/mrv2022.
Attending the Meeting as a Non-Registered Holder
Only registered holders of Common Shares, or the persons they appoint as their proxies, are permitted to vote shares and submit questions at the Meeting. In many cases, Common Shares beneficially owned by a holder (Non-Registered Holder) are registered either in the name of an Intermediary or in the name of a Depository. In order for a Non-Registered Holder to vote their Common Shares at the Meeting, they must carefully follow the procedures and instructions received from the Intermediary.
Attending the Meeting as a Guest
Guests, including Non-Registered Holders, can attend the Meeting, but will not have the ability to ask questions or vote during the Meeting. Guests can join the meeting by visiting: www.virtualshareholdermeeting.com/mrv2022.
Technical Assistance during the Meeting
If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be posted on the Virtual Shareholder Meeting log in page.
About
Miravo is a Canadian-focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005303/en/
Investor Relations
905 326 1888 ext 60
stefan@bristolir.com
Source:
FAQ
When will Miravo Healthcare release its Q1 2022 financial results?
What time is the Miravo Healthcare Annual Meeting of Shareholders?
How can I attend the Miravo Healthcare virtual meeting?
What materials were sent to shareholders for the meeting?